A “landmark” agreement has been struck to provide access to Commonwealth-subsidised medicines and support for aged care, among other measures.
Firm: Maddocks (Commonwealth Department of Health).
The agreement also “sets the price that is paid to pharmacists for dispensing medicines under the Pharmaceutical Benefits Scheme, which is expected to be $16 billion in Commonwealth spending over the five-year term of the agreement”, Maddocks said in a statement.
Value: $16 billion in Commonwealth spending over the five-year term of the agreement.
Area: Healthcare, government.
Key players: The Maddocks team was led by partner Andrew Whiteside, who was supported by special counsel Paul Ellis and lawyer Xinyu Zhang.
Deal significance: Maddocks healthcare sector leader Lucille Scomazzon said: “[Maddocks’] work on the 7CPA is another significant achievement for our [healthcare sector] team, showcasing the depth of our expertise in the pharmacy and pharmaceutical sectors. Congratulations Andrew and the team.”
The firm’s Commonwealth government sector leader Simonetta Astolfi added: “The 7CPA is another example of the great work we are doing for Commonwealth [government] clients and its signing is a proud achievement for the firm.”